Brief: Urogen Pharma Files For Mixed Shelf Offering Of Up To $250 Million - SEC Filing
20/12/2019 21:24
Dec 20 (Reuters) - Urogen Pharma Ltd UR8.F :
* UROGEN PHARMA FILES FOR MIXED SHELF OFFERING OF UP TO $250
MILLION - SEC FILING
Source text for Eikon: https://bit.ly/2sMWr8A
Further company coverage: UR8.F
((Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors